Competition in the Ukrainian laboratory diagnostics market is intensifying, which could lead to price wars, said Mykola Skavronsky, deputy CEO of Sinevo Ukraine, in an interview with Interfax-Ukraine.
“The number of laboratories has increased after COVID-19, and there are fewer people in the country, so the cost of attracting customers has increased significantly. This could lead to dumping, discounts, and even an increase in drug kickbacks,” he said.
Skavronsky added that the cost of services has also increased due to the devaluation of the hryvnia and the weakening of the dollar against the euro, which forced the company to raise prices by 10-15%.
Sinevo Ukraine is part of the Medicover Group, an international holding company in the field of medical and diagnostic services, whose shares are listed on the Stockholm Stock Exchange.
COMPETITION, price wars, Sinevo Ukraine
Related:
